Audit and Feedback to Reduce Broad-Spectrum Antibiotic Use among Intensive Care Unit Patients A Controlled Interrupted Time Series Analysis | Infection Control & Hospital Epidemiology | Cambridge Core (original) (raw)

References

  1. Pakyz, AL, MacDougall, C, Oinonen, M, Polk, RE. Trends in antibacterial use in US academic health centers: 2002 to 2006. Arch Intern Med 2008;168:2254–2260.CrossRefGoogle ScholarPubMed

  2. Ansari, F, Erntell, M, Goossens, H, Davey, P. The European surveillance of antimicrobial consumption (ESAC) point-prevalence survey of antibacterial use in 20 European hospitals in 2006. Clin Infect Dis 2009;49:1496–1504.CrossRefGoogle ScholarPubMed

  3. Hecker, MT, Aron, DC, Patel, NP, Lehmann, MK, Donskey, CJ. Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity. Arch Intern Med 2003;163:972–978.CrossRefGoogle ScholarPubMed

  4. Dellit, TH, Owens, RC, McGowan, JE Jr., et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007;44:159–177.CrossRefGoogle Scholar

  5. Lawrence, KL, Kollef, MH. Antimicrobial stewardship in the intensive care unit: advances and obstacles. Am J Respir Crit Care Med 2009;179:434–438.CrossRefGoogle ScholarPubMed

  6. Brown, EM, Nathwani, D. Antibiotic cycling or rotation: a systematic review of the evidence of efficacy. J Anrimicrob Chemother 2005;55:6–9.CrossRefGoogle ScholarPubMed

  7. Vincent, JL, Relio, J, Marshall, J, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009;302:2323–2329.CrossRefGoogle Scholar

  8. Kaki, R, Elligsen, M, Walker, S, Simor, A, Palmay, L, Daneman, N. Impact of antimicrobial stewardship in critical care: a systematic review. J Antimicrob Chemother 2011;66:1223–1230.CrossRefGoogle ScholarPubMed

  9. Fan, E, Laupacis, A, Pronovost, PJ, Guyatt, GH, Needham, DM. How to use an article about quality improvement. JAMA 2010; 304:2279–2287.CrossRefGoogle ScholarPubMed

  10. Polk, RE, Fox, C, Mahoney, A, Letcavage, J, MacDougall, C. Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. Clin Infect Dis 2007;44:664–670.CrossRefGoogle ScholarPubMed

  11. Anderson, DJ, Kaye, KS, Classen, D, et al. Strategies to prevent surgical site infections in acute care hospitals. Infect Control Hosp Epidemiol 2008;29(suppl 1):S51–S61.CrossRefGoogle ScholarPubMed

  12. Hussey, MA, Hughes, JP. Design and analysis of stepped wedge cluster randomized trials. Contemp Clin Trials 2007;28:182–191.CrossRefGoogle ScholarPubMed

  13. Gibbs, L, Kakis, A, Weinstein, P, Conte, JE Jr. Bone wax as a risk factor for surgical-site infection following neurospinal surgery. Infect Control Hosp Epidemiol 2004;25:346–348.CrossRefGoogle ScholarPubMed

  14. Geissler, A, Gerbeaux, P, Granier, I, Blanc, P, Facon, K, Durand-Gasselin, J. Rational use of antibiotics in the intensive care unit: impact on microbial resistance and costs. Intensive Care Med 2003;29:49–54.CrossRefGoogle ScholarPubMed

  15. Marra, AR, de Almeida, SM, Correa, L, et al. The effect of limiting antimicrobial therapy duration on antimicrobial resistance in the critical care setting. Am J Infect Control 2009;37:204–209.CrossRefGoogle ScholarPubMed

  16. Brahmi, N, Biel, Y, Kouraichi, N, Ben, HR, Thabet, H, Amamou, M. Impact of antibiotic use and prescribing policy in a Tunisian intensive care unit [in French]. Med Mai Infect 2006;36:460–465.CrossRefGoogle Scholar

  17. Starr, JM, Campbell, A, Renshaw, E, Poxton, IR, Gibson, GJ. Spatio-temporal stochastic modelling of Clostridium difficile . J Hosp Infect 2009;71:49–56.CrossRefGoogle ScholarPubMed

  18. Valiquette, L, Cossette, B, Garant, MP, Diab, H, Pepin, J. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis 2007; 45(suppl 2):S112–S121.CrossRefGoogle ScholarPubMed

  19. Ntagiopoulos, PG, Paramythiotou, E, Antoniadou, A, Giamarellou, H, Karabinis, A. Impact of an antibiotic restriction policy on the antibiotic resistance patterns of gram-negative microorganisms in an intensive care unit in Greece. Int J Antimicrob Agents 2007; 30:360–365.CrossRefGoogle Scholar

  20. Brahmi, N, Biel, Y, Kouraichi, N, et al. Impact of ceftazidime restriction on gram-negative bacterial resistance in an intensive care unit. J Infect Chemother 2006;12:190–194.CrossRefGoogle Scholar

  21. Elligsen, M, Walker, S, Simor, A, Daneman, N. Antimicrobial prospective-audit and feedback in critical care: program implementation, experience and challenges. Can J Hosp Pharm (forthcoming).Google Scholar